| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |